Third Generic Zantac Drug Recalled in One Week

Third Generic Zantac Drug Recalled in One Week
Nov 15, 2019 Gayle Gerling Pettinga Read Time: < 1 minute

November 15, 2019 – In the past week, three generic Zantac drugs have been recalled from pharmacy shelves across the U.S as concern grows that the drugs are linked to an increased risk of cancer. Amneal Pharmaceuticals recalled dozens of lots of Ranitidine Tablets and Ranitidine Syrup.The decision was made amid concerns that the Ranitidine Tablets and Ranitidine Syrup contain dangerous amounts of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, above the limit established by the FDA. So far, there have been nine Ranitidine recalls.

Reference: 10WBNS TEGNA Tegna. “New Generic Zantac Recall over Cancer Fear Makes It 3 in Past Week.” WBNS-10TV Columbus, Ohio | Columbus News, Weather & Sports, 13 Nov. 2019, https://www.10tv.com/article/money/consumer/new-generic-zantac-recall-over-cancer-fear-makes-it-3-past-week-2019-nov/530-bd0b5491-90f0-4c36-94da-ca2f75698c14

By: Gayle Gerling Pettinga

Born and raised in Evansville, Gayle is a respected, experienced lawyer and a valued community leader. She graduated near the top of her class at Indiana University’s prestigious Maurer School of Law. She’s practiced law with one of the largest firms in Indianapolis as well as one of the largest pharmaceutical companies in the world. And that means she knows how big law firms and big companies think and how they operate – and she will put that knowledge to work for you.

Gayle has received numerous awards and honors including Martindale-Hubbell — Peer Review Rated: AV®, American Institute of Personal Injury Attorneys 10 Best Attorneys in Indiana for Exceptional and Outstanding Client Service, and YWCA Evansville 100 Years, 100 Women Honoree, 2011.

(888) 437-5464
Jump to a Topic  Schedule Your Free Consultation